US$ 25.75
retatrutide pcos FOR WOMEN: on GLP-1 Weight Loss #retatrutide #glp1 #pcos Is Reta Good For Pcos
Description
The GIP component may actually reduce GLP-1-related nausea compared to single-agonist medications

Petersen KM, Bgevig S, Holst JJ, Knop FK, Christensen MB, et al

(2025) showed every-14-day dosing retains approximately 72% of weekly-dosing weight loss while cutting dose frequency in half
Duration of maintenance dosing The phase 2 trial ran for 48 weeks, and the weight loss curve had not fully plateaued by that point

These side effects are usually mild and decrease over time
Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P)